US FDA clears St Jude Medical's SVG Proxis embolic protection device
This article was originally published in Clinica
Executive Summary
The US FDA has approved for sale St Paul, Minnesota-based St Jude Medical's 7F Proxis embolic protection system for extracting debris that may become dislodged during interventional procedures to treat blocked saphenous vein grafts (SVGs).